Comment
doi: 10.1001/jamaoncol.2021.2316.
Forging a Path for Metformin Use in Inoperable Locally Advanced Non-Small Cell Lung Cancer
Affiliations
- PMID: 34323949
- DOI: 10.1001/jamaoncol.2021.2316
Item in Clipboard
Comment
Forging a Path for Metformin Use in Inoperable Locally Advanced Non-Small Cell Lung Cancer
JAMA Oncol.
.
No abstract available
Comment on
-
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial.JAMA Oncol. 2021 Sep 1;7(9):1324-1332. doi: 10.1001/jamaoncol.2021.2318. JAMA Oncol. 2021. PMID: 34323922 Free PMC article. Clinical Trial.
-
Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: The OCOG-ALMERA Randomized Clinical Trial.JAMA Oncol. 2021 Sep 1;7(9):1333-1341. doi: 10.1001/jamaoncol.2021.2328. JAMA Oncol. 2021. PMID: 34323924 Free PMC article. Clinical Trial.
Similar articles
-
A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non-Small-cell Lung Cancer.Clin Lung Cancer. 2017 May;18(3):340-343. doi: 10.1016/j.cllc.2016.12.003. Epub 2016 Dec 22. Clin Lung Cancer. 2017. PMID: 28065465 Clinical Trial.
-
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.Anticancer Drugs. 2007 Jul;18(6):713-9. doi: 10.1097/CAD.0b013e328082558a. Anticancer Drugs. 2007. PMID: 17762402 Clinical Trial.
-
[A randomized study on the effects of paclitaxel liposme and cisplatin induction chemotherapy followed concurrent chemoradiotherapy and sequential radiotherapy on locally advanced non-small cell lung cancer patients].Zhongguo Fei Ai Za Zhi. 2011 Feb;14(2):137-40. doi: 10.3779/j.issn.1009-3419.2011.02.06. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21342644 Free PMC article. Clinical Trial. Chinese.
-
Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancer.Curr Oncol Rep. 2003 Jul;5(4):313-7. doi: 10.1007/s11912-003-0073-z. Curr Oncol Rep. 2003. PMID: 12781074 Review.
-
Chemoradiotherapy for lung cancer: current status and perspectives.Int J Clin Oncol. 2004 Dec;9(6):435-43. doi: 10.1007/s10147-004-0453-x. Int J Clin Oncol. 2004. PMID: 15616873 Review.
Cited by
-
Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?Front Oncol. 2022 Dec 14;12:1016217. doi: 10.3389/fonc.2022.1016217. eCollection 2022. Front Oncol. 2022. PMID: 36591457 Free PMC article. Review.
-
Addition of metformin to non-small-cell lung cancer patients with or without diabetes.Thorac Cancer. 2023 Jan;14(2):218-219. doi: 10.1111/1759-7714.14756. Epub 2022 Nov 30. Thorac Cancer. 2023. PMID: 36450700 Free PMC article. No abstract available.
-
Metformin: A promising drug for human cancers.Oncol Lett. 2022 May 12;24(1):204. doi: 10.3892/ol.2022.13325. eCollection 2022 Jul. Oncol Lett. 2022. PMID: 35720480 Free PMC article. Review.
-
Metformin Intervention-A Panacea for Cancer Treatment?Cancers (Basel). 2022 Mar 4;14(5):1336. doi: 10.3390/cancers14051336. Cancers (Basel). 2022. PMID: 35267644 Free PMC article. Review.
-
Metabolic response to radiation therapy in cancer.Mol Carcinog. 2022 Feb;61(2):200-224. doi: 10.1002/mc.23379. Epub 2021 Dec 27. Mol Carcinog. 2022. PMID: 34961986 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
